Treatment of multiple myeloma and arterial thrombosis

Annals of Hematology

Volumn 89, Issue 4, 2010, Pages 419-420

  Raven, Wouter ^a   Berghout, Arie ^a   Van Houten, Anja ^a   Leebeek, Frank W G ^b  

^a Maasstad Hospital Rotterdam   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BENCE JONES PROTEIN; BISPHOSPHONIC ACID DERIVATIVE; DEXAMETHASONE; DIPYRONE; DOXORUBICIN; INFUSION FLUID; MORPHINE; PARACETAMOL; VINCRISTINE; ANTINEOPLASTIC AGENT;

ADULT; ARTERY THROMBOSIS; ATHEROSCLEROSIS; BACKACHE; BLOOD ANALYSIS; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; COLON OBSTRUCTION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN TISSUE; HYPERCALCEMIA; IMMUNOPHENOTYPING; INFERIOR MESENTERIC ARTERY; INTESTINE NECROSIS; LAPAROTOMY; LETTER; MESENTERIC ARTERY OCCLUSION; MULTIPLE MYELOMA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEINURIA; SPINE RADIOGRAPHY; ARTERY; AUTOPSY; FATALITY; MIDDLE AGED; PATHOLOGY; THROMBOSIS;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ARTERIES; AUTOPSY; FATAL OUTCOME; FEMALE; HUMANS; MIDDLE AGED; MULTIPLE MYELOMA; THROMBOSIS;

EID: 77649308341     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-009-0803-x     Document Type: Letter

References (11)

1. Lip YH, Chin BSP, Blann AD (2002) Cancer and the prothrombotic state. Lancet Oncol 3:27-34
2. Zangari M, Elice F, Fink L et al (2007) Thrombosis in multiple myeloma. Expert Rev Anticancer Ther 7:307-315
3. Kristinsson SY, Fears RH, Gridley G et al (2008) Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma. Blood 112:3582-3586
4. Barlogie B, Tricot G, Anaissie E et al (2006) Thalidomide and hematopoietic-cell transplantation for multiple myeloma. N Engl J Med 354:1021-1030
5. Auwerda JJA, Sonneveld P, de Maat MPM et al (2007) Haematologica 92:279-280
6. Marion AMW, Auwerda JJA, Lisman T et al (2008) Prospective evaluation of coagulopathy in multiple myeloma patients before, during and after various chemotherapeutic regimens. Leuk Res 32:1078-1084
7. Kyrle PA, Minar E, Hirschl M et al (2000) High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med 343:457-462
8. Goz M, Nesimi Eren M, Cakir O (2008) Arterial thrombosis and thalidomide. J Thromb Thrombolysis 25:224-226
9. Minnema MC, Breitkreuz I, Auwerda JJA et al (2004) Prevention of venous thromboembolism with low molecular-weight heparin in patients with multiple myeloma treated with thalidomide and chemotherapy. Leukemia 18:2044-2046
10. Palumbo A, Rajkumar SV, Dimopoulos MA et al (2008) Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma. Leukemia 22:414-423
11. Palumbo A, Cavo M, Bringhen S et al (2008) Enoxin versus aspirin versus low-fixed-dose of warfarin in newly diagnosed myeloma patients treated with thalidomide containing regimens: a randomized controlled trial. Haematologica 93(suppl 1):0910